Weiqiong Zuo

602 citations

21 papers · 522 indexed · h-index 14

Toxicology top 10%
Organic Chemistry top 10%
- Quinazolinone synthesis and applications 4
Molecular Biology
- Protein Degradation and Inhibitors 6
- Cancer therapeutics and mechanisms 4
- Ubiquitin and proteasome pathways 4
- Biochemical and Molecular Research 3
Infectious Diseases
- Tuberculosis Research and Epidemiology 3
Hematology
- Multiple Myeloma Research and Treatments 3
Hepatology
- Hepatitis C virus research 4

Co-authors: Ningyu Wang Luoting Yu Cuiting Peng Ying Xu Yongxia Zhu Xinyu You Tinghong Ye Lidan Zhang
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Scientific Reports (2 papers)Journal of Medicinal Chemistry (1 paper)Biochemical Pharmacology (1 paper)
Partner nations: China United States

In The Last Decade

Weiqiong Zuo

21 papers receiving 517 citations

Peers

Countries citing papers authored by Weiqiong Zuo

Since Specialization

Citations

This map shows the geographic impact of Weiqiong Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqiong Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqiong Zuo more than expected).

Fields of papers citing papers by Weiqiong Zuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqiong Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqiong Zuo. The network helps show where Weiqiong Zuo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weiqiong Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiqiong Zuo Line = papers co-authored together Weiqiong Zuo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor European Journal of Medicinal Chemistry ·Rong Hu,Wanli Wang,Ying-Yue Yang,Xia-Tong Hu,Qiwei Wang,Weiqiong Zuo,Ying Xu,Qiang Feng,Ningyu Wang	2021	37
2	BRD4 inhibition sensitizes aggressive non-Hodgkin lymphomas to PI3Kδ inhibitors by suppressing PI3K reactivation and c-MYC expression. American Journal of Cancer Research ·Weiqiong Zuo,Yongxia Zhu,Zhihao Liu,Yong Xia,Ying Xu,Cuiting Peng,Luoting Yu,Ningyu Wang	2021	3
3	Design, synthesis and structure-activity relationship study of piperazinone-containing thieno[3,2-d]pyrimidine derivatives as new PI3Kδ inhibitors Bioorganic & Medicinal Chemistry Letters ·Ningyu Wang,Weiqiong Zuo,Rong Hu,Wanli Wang,Yongxia Zhu,Ying Xu,Luoting Yu,Zhihao Liu	2020	4
4	Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors European Journal of Medicinal Chemistry ·Ningyu Wang,Ying Xu,Kun-Jie Xiao,Weiqiong Zuo,Yongxia Zhu,Rong Hu,Wanli Wang,Yao Shi,Luoting Yu,Zhihao Liu	2020	34
5	Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma Bioorganic Chemistry ·Weiqiong Zuo,Rong Hu,Wanli Wang,Yongxia Zhu,Ying Xu,Luoting Yu,Zhihao Liu,Ningyu Wang	2020	9
6	Novel Dual BET and PLK1 Inhibitor WNY0824 Exerts Potent Antitumor Effects in CRPC by Inhibiting Transcription Factor Function and Inducing Mitotic Abnormality Molecular Cancer Therapeutics ·Ying Xu,Qianqian Wang,Kun-Jie Xiao,Zhihao Liu,Lifeng Zhao,Xuejiao Song,Xi Hu,Zhanzhan Feng,Tiantao Gao,Weiqiong Zuo,Jun Zeng,Ningyu Wang,Luoting Yu	2020	16
7	Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway Biochemical Pharmacology ·Yongxia Zhu,Weiqiong Zuo,Lijuan Chen,Shasha Bian,Jiayu Jing,Cailin Gan,Xiuli Wu,Hongyao Liu,Xingping Su,Wanglai Hu,Yuqi Guo,Yue Wang,Tinghong Ye	2019	36
8	Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis Biomedicine & Pharmacotherapy ·Qiang Xue,Zhihao Liu,Zhanzhan Feng,Ying Xu,Weiqiong Zuo,Qianqian Wang,Tiantao Gao,Jun Zeng,Xi Hu,Fanfan Jia,Yongxia Zhu,Yong Xia,Luoting Yu	2019	23
9	Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis Cancer Letters ·Tiantao Gao,Quanfang Hu,Xi Hu,Qian Lei,Zhanzhan Feng,Xi Yu,Cuiting Peng,Xuejiao Song,Hualong He,Ying Xu,Weiqiong Zuo,Jun Zeng,Zhihao Liu,Luoting Yu	2018	32
10	A novel small-molecule YLT256 inhibits proliferation and induces apoptosis both in vitro and in vivo in solid tumors Biomedicine & Pharmacotherapy ·Hongxia Deng,Jun Zeng,Yongxia Zhu,Tinghong Ye,Yong Xia,Yao Shi,Ningyu Wang,Lidan Zhang,Xuejiao Song,Weiqiong Zuo,Tiantao Gao,Luoting Yu	2016	1
11	Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma Scientific Reports ·Yongxia Zhu,Tinghong Ye,Xi Yu,Qian Lei,Fangfang Yang,Yong Xia,Xuejiao Song,Li Liu,Hongxia Deng,Tiantao Gao,Cuiting Peng,Weiqiong Zuo,Ying Xiong,Lidan Zhang,Ningyu Wang,Lifeng Zhao,Yongmei Xie,Luoting Yu,Yuquan Wei	2016	64
12	Synthesis and biological evaluation of N-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)benzenesulfonamide derivatives as new BET bromodomain inhibitors for anti-hematologic malignancies activities Molecular Diversity ·Li Liu,Yongxia Zhu,Zhihao Liu,Tinghong Ye,Weiqiong Zuo,Cuiting Peng,Kun-Jie Xiao,Ningyu Wang,Luoting Yu	2016	2
13	Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis Scientific Reports ·Chao Gao,Cuiting Peng,Yao Shi,Xinyu You,Kai Ran,Lu Xiong,Tinghong Ye,Lidan Zhang,Ningyu Wang,Yongxia Zhu,Kun Liu,Weiqiong Zuo,Luoting Yu,Yuquan Wei	2016	39
14	A new series of HCV inhibitors based on a 2-(thieno[2,3b]pyridin-2-yl)-1,3,4-oxadiazole scaffold RSC Advances ·Weiqiong Zuo,Ningyu Wang,Yongxia Zhu,Li Liu,Kun-Jie Xiao,Lidan Zhang,Chao Gao,Zhihao Liu,Xinyu You,Yao Shi,Cuiting Peng,Kai Ran,Hong Tang,Luoting Yu	2016	14
15	ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth RSC Advances ·Tiantao Gao,Lidan Zhang,Yongxia Zhu,Xuejiao Song,Qiang Feng,Qian Lei,Suxia Shi,Hongxia Deng,Menghua Xiong,Xinyu You,Weiqiong Zuo,Li Liu,Cuiting Peng,Ningyu Wang,Tinghong Ye,Yong Xia,Luoting Yu	2016	10
16	Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives Bioorganic & Medicinal Chemistry Letters ·Cuiting Peng,Chao Gao,Ningyu Wang,Xinyu You,Lidan Zhang,Yongxia Zhu,Ying Xv,Weiqiong Zuo,Kai Ran,Hongxia Deng,Qian Lei,Kun-Jie Xiao,Luoting Yu	2015	41
17	Discovery of novel N-(5-(tert-butyl)isoxazol-3-yl)-N′-phenylurea analogs as potent FLT3 inhibitors and evaluation of their activity against acute myeloid leukemia in vitro and in vivo Bioorganic & Medicinal Chemistry ·Ying Xu,Ningyu Wang,Xuejiao Song,Qian Lei,Tinghong Ye,Xinyu You,Weiqiong Zuo,Yong Xia,Lidan Zhang,Luoting Yu	2015	17
18	Discovery of Imidazo[2,1-b]thiazole HCV NS4B Inhibitors Exhibiting Synergistic Effect with Other Direct-Acting Antiviral Agents Journal of Medicinal Chemistry ·Ningyu Wang,Ying Xu,Weiqiong Zuo,Kun-Jie Xiao,Li Liu,Xiu‐Xiu Zeng,Xinyu You,Lidan Zhang,Chao Gao,Zhihao Liu,Tinghong Ye,Yong Xia,Ying Xiong,Xuejiao Song,Qian Lei,Cuiting Peng,Hong Tang,Shengyong Yang,Yuquan Wei,Luoting Yu	2015	37
19	Discovery and structure–activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors Bioorganic & Medicinal Chemistry Letters ·Ningyu Wang,Weiqiong Zuo,Ying Xu,Chao Gao,Xiu‐Xiu Zeng,Lidan Zhang,Xinyu You,Cuiting Peng,Yang Shen,Shengyong Yang,Yuquan Wei,Luoting Yu	2014	45
20	Synthesis and structure–activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents Bioorganic & Medicinal Chemistry Letters ·Chao Gao,Tinghong Ye,Ningyu Wang,Xiu‐Xiu Zeng,Lidan Zhang,Ying Xiong,Xinyu You,Yong Xia,Ying Xu,Cuiting Peng,Weiqiong Zuo,Yuquan Wei,Luoting Yu	2013	56

About Weiqiong Zuo

Weiqiong Zuo is a scholar working on Hepatology, Hematology and Infectious Diseases, having authored 21 papers that have together received 522 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Quinazolinone synthesis and applications (4 papers), Cancer therapeutics and mechanisms (4 papers), Ubiquitin and proteasome pathways (4 papers), Hepatitis C virus research (4 papers), Tuberculosis Research and Epidemiology (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Toxicology (23 citations), Organic Chemistry (181 citations) and Molecular Biology (316 citations). Weiqiong Zuo has collaborated with scholars based in China and United States. Frequent co-authors include Ningyu Wang, Luoting Yu, Cuiting Peng, Ying Xu, Yongxia Zhu, Xinyu You, Tinghong Ye, Lidan Zhang, Yuquan Wei and Zhihao Liu. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact